¼¼°èÀÇ °ü»ó µ¿¸Æ¼º ½ÉÀ庴 ¿µ»ó Áø´Ü ±â±â ½ÃÀå
Coronary Heart Disease Diagnostic Imaging Devices
»óǰÄÚµå : 1774739
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 392 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ °ü»ó µ¿¸Æ¼º ½ÉÀ庴 ¿µ»ó Áø´Ü ±â±â ½ÃÀåÀº 2030³â±îÁö 26¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 19¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â °ü»ó µ¿¸Æ¼º ½ÉÀ庴 ¿µ»ó Áø´Ü ±â±â ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 5.4%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 26¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µÀº CAGR6.5%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á±îÁö 12¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. X¼± ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ CAGR·Î 3.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 5¾ï 720¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ °ü»ó µ¿¸Æ¼º ½ÉÀ庴 ¿µ»ó Áø´Ü ±â±â ½ÃÀåÀº 2024³â¿¡ 5¾ï 720¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â°£ CAGR 8.7%·Î 2030³â±îÁö 5¾ï 1,650¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 2.5%¿Í 5.4%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.5%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ °ü»ó µ¿¸Æ¼º ½ÉÀ庴 ¿µ»ó Áø´Ü ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿Ö ¿µ»ó Áø´Ü ±â±â°¡ °ü»óµ¿¸Æ ½ÉÀåÁúȯÀ» ¹ß°ßÇÏ´Â µ¥ ÇʼöÀûÀΰ¡?

°ü»óµ¿¸Æ¼º ½ÉÀåÁúȯ(CHD)Àº ¿©ÀüÈ÷ Àü ¼¼°è »ç¸Á¿øÀÎ 1À§·Î, Á¶±â ¹ß°ß°ú Á¶±â °³ÀÔÀ» À§ÇØ Ã·´Ü ¿µ»óÁø´Ü ±â¼úÀÌ ÇÊ¿äÇÕ´Ï´Ù. ½ÉÃÊÀ½ÆÄ, °ü»óµ¿¸Æ Á¶¿µ¼ú, ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT), ÀÚ±â°ø¸í¿µ»ó(MRI) µîÀÇ ¿µ»ó Áø´Ü ±â±â´Â °ü»óµ¿¸ÆÀÇ »óŸ¦ Æò°¡Çϰí, ¸·ÈûÀ» °¨ÁöÇϰí, ½ÉÀå ±â´ÉÀ» Æò°¡ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÁÂ½Ä »ýȰ½À°ü, °Ç°­¿¡ ÇØ·Î¿î ½Ä½À°ü, °í·ÉÈ­·Î ÀÎÇØ CHDÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó º¸´Ù Á¤È®ÇÏ°í ºñħ½ÀÀûÀÎ ½Ç½Ã°£ ¿µ»ó ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×ÀÇ ¹ßÀüÀ¸·Î Áø´Ü Á¤È®µµ¿Í ȯÀÚ ¿¹Èİ¡ °³¼±µÇ°í ÀÖÀ¸¸ç, CHD Á¶±â ¹ß°ßÀÇ Çʿ伺ÀÌ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó ¿µ»ó Áø´Ü ±â±â´Â ´õ¿í Á¤±³ÇØÁö°í, ½Ç½Ã°£ ºÐ¼®°ú ÈÞ´ëÇü ¿É¼ÇÀ¸·Î ´Ù¾çÇÑ È¯ÀÚ±º¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù.

°ü»óµ¿¸Æ ¿µ»óÁø´Ü¿¡ ¾î¶² Çõ½ÅÀÌ °ü»óµ¿¸Æ ¿µ»óÁø´Ü¿¡ º¯È­¸¦ °¡Á®¿Ã °ÍÀΰ¡?

°ü»óµ¿¸ÆÁúȯ ¿µ»óÁø´Ü ½ÃÀåÀº °íÇØ»óµµ CT Ç÷°üÁ¶¿µ¼ú, 3D ¿µ»ó, AI¸¦ Ȱ¿ëÇÑ Áø´Ü µî ±â¼ú Çõ½ÅÀ¸·Î ÀÎÇØ ´«ºÎ½Å ¹ßÀüÀ» °ÅµìÇϰí ÀÖ½À´Ï´Ù. CT¿Í ¾çÀüÀÚ¹æ»ç¼±´ÜÃþÃÔ¿µ(PET)°ú ´Ü±¤ÀÚ¹æ»ç¼±´ÜÃþÃÔ¿µ(SPECT)À» °áÇÕÇÑ ÇÏÀ̺긮µå ¿µ»óÁø´Ü½Ã½ºÅÛÀÇ °³¹ß·Î Áø´Ü Á¤È®µµ´Â ´õ¿í Çâ»óµÇ¾ú½À´Ï´Ù. ´õ¿í Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ŭ¶ó¿ìµå ±â¹Ý µ¥ÀÌÅÍ °øÀ¯¿Í ¿ø°Ý ¿µ»ó Áø´Ü ¼Ö·ç¼ÇÀÇ ÅëÇÕÀº ƯÈ÷ ¿ø°ÝÁö³ª ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ ÷´Ü ¿µ»ó Áø´Ü ¼­ºñ½ºÀÇ ¹üÀ§¸¦ È®ÀåÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀÌ º¸´Ù È¿À²ÀûÀÌ°í ºñ¿ë È¿À²ÀûÀÎ Áø´Ü ¹æ¹ýÀ» ã°í ÀÖ´Â °¡¿îµ¥, ÀÌ·¯ÇÑ Ã·´Ü ±â¼úµéÀº ½ÃÀå ¼ºÀåÀ» Å©°Ô ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

CHD À¯º´·ü Áõ°¡´Â ¾î¶»°Ô ½ÃÀå ¼ö¿ä¸¦ °ßÀÎÇϰí Àִ°¡?

¼¼°èÀûÀ¸·Î °ü»óµ¿¸Æ¼º ½ÉÀåÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÷´Ü ¿µ»ó Áø´Ü ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ºñ¸¸À² Áõ°¡, °íÇ÷¾Ð, ´ç´¢º´, Èí¿¬ °ü·Ã Áúȯ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ CHD ȯÀÚ°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó Á¤±âÀûÀÎ ½ÉÀå °ËÁøÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¼¼°è °¢±¹ÀÇ Á¤ºÎ¿Í ÀÇ·á±â°üÀº ¿¹¹æÀÇÇп¡ ÁßÁ¡À» µÎ°í Á¤±âÀûÀÎ °ËÁø ¹× ¿µ»óÁø´ÜÀ» ÅëÇÑ Á¶±â ¹ß°ßÀ» Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï±¹°¡ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®ÃæÀº ¿µ»óÁø´Ü ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼º Çâ»óÀ¸·Î À̾îÁ® ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿Í Á¤¹Ð Áø´ÜÀÇ ¹ßÀüÀº ÷´Ü ¿µ»óÁø´Ü ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» ´õ¿í Áõ°¡½ÃÄÑ CHDÀÇ Ç¥ÀûÈ­µÇ°í È¿°úÀûÀÎ Ä¡·á¸¦ º¸ÀåÇϰí ÀÖ½À´Ï´Ù.

°ü»óµ¿¸Æ À̹Ì¡ ±â±âÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀº ¹«¾ùÀΰ¡?

°ü»óµ¿¸ÆÁúȯ ¿µ»óÁø´Ü±â±â ½ÃÀåÀÇ ¼ºÀåÀº Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü, ÀÇ·áºñ ÁöÃâ Áõ°¡, ½ÉÀ庴 ¿¹¹æ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ¿µ»ó Áø´Ü ±â±â¿¡ AI ±â¹Ý ºÐ¼®ÀÌ ÅëÇյǸ鼭 Áø´Ü Á¤È®µµ°¡ Çâ»óµÇ¾î º¸´Ù ½Å¼ÓÇϰí È¿À²ÀûÀÎ Áúº´ ¹ß°ßÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ¶ÇÇÑ Àúħ½À ¹× ºñħ½ÀÀû ¿µ»ó ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CTA) ¹× MRI ±â¼úÀÇ Çõ½ÅÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µÀÇ È®´ë´Â ¸ð¹ÙÀÏ ¹× ÈÞ´ë¿ë ¿µ»ó ¼Ö·ç¼ÇÀÇ ±âȸ¸¦ âÃâÇÏ¿© º¸´Ù Æø³ÐÀº Á¢±Ù¼ºÀ» º¸ÀåÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á Á¤Ã¥ÀÇ Á¶±â ¹ß°ß ¹× ¿¹¹æÀû ¼øÈ¯±âÇп¡ ´ëÇÑ °­Á¶·Î °ü»óµ¿¸Æ ¿µ»ó Áø´Ü ±â±â ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

ºÎ¹®

¸ð´Þ¸®Æ¼(ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ, X¼±, ÃÊÀ½ÆÄ, ÀÚ±â°ø¸í¿µ»ó(MRI), ÇÙÀÇÇÐ), ¿ëµµ(ºÎÁ¤¸Æ ¿ëµµ, ½ÉÀå ¹ßÀÛ ¿ëµµ, ½ÉºÎÀü ¿ëµµ, ¼±Ãµ¼º ½ÉÁúȯ ¿ëµµ, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø ÃÖÁ¾ ¿ëµµ, ¿µ»ó Áø´Ü¼¾ÅÍ ÃÖÁ¾ ¿ëµµ, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ÃÖÁ¾ ¿ëµµ, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Coronary Heart Disease Diagnostic Imaging Devices Market to Reach US$2.6 Billion by 2030

The global market for Coronary Heart Disease Diagnostic Imaging Devices estimated at US$1.9 Billion in the year 2024, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Computed Tomography, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the X-Ray segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$507.2 Million While China is Forecast to Grow at 8.7% CAGR

The Coronary Heart Disease Diagnostic Imaging Devices market in the U.S. is estimated at US$507.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$516.5 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Coronary Heart Disease Diagnostic Imaging Devices Market - Key Trends & Drivers Summarized

Why Are Diagnostic Imaging Devices Crucial for Coronary Heart Disease Detection?

Coronary heart disease (CHD) remains a leading cause of mortality worldwide, necessitating advanced diagnostic imaging technologies for early detection and intervention. Imaging devices such as echocardiography, coronary angiography, computed tomography (CT), and magnetic resonance imaging (MRI) play a critical role in assessing coronary artery conditions, detecting blockages, and evaluating heart function. The increasing prevalence of CHD due to sedentary lifestyles, unhealthy diets, and aging populations has spurred demand for more accurate, non-invasive, and real-time imaging solutions. Advancements in artificial intelligence (AI) and machine learning have also enhanced the capabilities of these devices, improving diagnostic precision and patient outcomes. As the need for early CHD detection continues to grow, imaging devices are becoming more sophisticated, with real-time analytics and portable options improving accessibility for diverse patient populations.

What Technological Innovations Are Transforming Coronary Imaging?

The diagnostic imaging market for coronary heart disease has seen remarkable advancements, with innovations such as high-resolution CT angiography, 3D imaging, and AI-powered diagnostics. These technologies enable physicians to detect coronary artery plaque, stenosis, and myocardial perfusion with greater accuracy and less radiation exposure. The development of hybrid imaging systems that combine CT with positron emission tomography (PET) or single-photon emission computed tomography (SPECT) has further improved diagnostic accuracy. Additionally, the integration of cloud-based data sharing and telecardiology solutions is expanding the reach of advanced imaging services, particularly in remote and underserved regions. As healthcare providers seek more efficient and cost-effective diagnostic methods, these cutting-edge technologies are poised to drive substantial market growth.

How Is the Growing Prevalence of CHD Driving Market Demand?

The increasing global burden of coronary heart disease has significantly driven demand for advanced diagnostic imaging devices. Factors such as rising obesity rates, hypertension, diabetes, and smoking-related conditions have contributed to an uptick in CHD cases, necessitating regular cardiac assessments. Governments and healthcare organizations worldwide are focusing on preventive healthcare, encouraging routine screenings and early detection through imaging diagnostics. Additionally, the expansion of healthcare infrastructure in developing economies has led to greater accessibility of imaging technologies, bolstering market growth. The push for personalized medicine and precision diagnostics has further increased the adoption of advanced imaging solutions, ensuring targeted and effective CHD treatments.

What Are the Key Growth Drivers for Coronary Imaging Devices?

The growth in the coronary heart disease diagnostic imaging devices market is driven by several factors, including continuous technological advancements, increasing healthcare expenditure, and rising awareness of heart disease prevention. The integration of AI-powered analytics in imaging devices has enhanced diagnostic accuracy, enabling faster and more efficient disease detection. Furthermore, the increasing demand for minimally invasive and non-invasive imaging solutions has spurred innovation in computed tomography angiography (CTA) and MRI technologies. The expansion of telemedicine and remote monitoring has also created opportunities for mobile and portable imaging solutions, ensuring broader accessibility. As healthcare policies emphasize early detection and preventive cardiology, the market for coronary imaging devices is expected to witness sustained growth.

SCOPE OF STUDY:

The report analyzes the Coronary Heart Disease Diagnostic Imaging Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Modality (Computed Tomography, X-Ray, Ultrasound, Magnetic Resonance Imaging, Nuclear Medicine); Application (Arrhythmia Application, Heart Attack Application, Heart Failure Application, Congenital Heart Conditions Application, Other Applications); End-Use (Hospitals End-Use, Diagnostic Imaging Centers End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â